These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 6109417

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Somatostatin: a potent inhibitor of ACTH-hypersecretion in adrenal insufficiency.
    Fehm HL, Voigt KH, Lang R, Beinert KE, Raptis S, Pfeiffer EF.
    Klin Wochenschr; 1976 Feb 15; 54(4):173-5. PubMed ID: 1256005
    [Abstract] [Full Text] [Related]

  • 3. Persistent hypersecretion of ACTH in treated Addison's disease.
    Child DF, Lewis F, Williams CP.
    J R Soc Med; 1990 Jun 15; 83(6):399-400. PubMed ID: 2166161
    [No Abstract] [Full Text] [Related]

  • 4. Failure of somatostatin and octreotide to acutely affect the hypothalamic-pituitary-adrenal function in patients with corticotropin hypersecretion.
    Ambrosi B, Bochicchio D, Fadin C, Colombo P, Faglia G.
    J Endocrinol Invest; 1990 Mar 15; 13(3):257-61. PubMed ID: 1973178
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Inhibitory effect of cyproheptadine on ACTH secretion in patients with Addison's disease.
    Loli P, Frascatani F, Gelli D, Maggioni M, Muratori F, Ronzoni M.
    Acta Endocrinol (Copenh); 1983 Jan 15; 102(1):111-5. PubMed ID: 6297209
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Loperamide, an opiate analogue, inhibits plasma ACTH levels in patients with Addison's disease.
    Ambrosi B, Bochicchio D, Faglia G.
    Clin Endocrinol (Oxf); 1986 May 15; 24(5):483-9. PubMed ID: 3024866
    [Abstract] [Full Text] [Related]

  • 11. A pituitary tumour with possible ACTH and TSH hypersecretion in a patient with Addison's disease and primary hypothyroidism.
    Aanderud S, Bassøe HH.
    Acta Endocrinol (Copenh); 1980 Oct 15; 95(2):181-4. PubMed ID: 6254305
    [Abstract] [Full Text] [Related]

  • 12. Plasma adrenocorticotrophic hormone in Addison's disease and its modification by the administration of adrenal steroids.
    BETHUNE JE, NELSON DH, THORN GW.
    J Clin Invest; 1957 Dec 15; 36(12):1701-7. PubMed ID: 13491701
    [No Abstract] [Full Text] [Related]

  • 13. Effect of meclastine, an H1-antihistamine, on plasma ACTH in adrenal insufficiency.
    Allolio B, Winkelmann W, Hipp FX.
    Acta Endocrinol (Copenh); 1981 May 15; 97(1):98-102. PubMed ID: 6261510
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. ACTH suppression after oral administration of cortisone in Addisonian and adrenalectomized patients.
    Aanderud S, Myking OL, Bassøe HH.
    Acta Endocrinol (Copenh); 1982 Aug 15; 100(4):588-94. PubMed ID: 6289586
    [Abstract] [Full Text] [Related]

  • 18. The effect of low-dose naloxone infusion on plasma ACTH and LH in patients with Cushing's and Addison's diseases.
    Moreira AC, Foss MC, Iazigi N, Verissimo JM.
    Horm Metab Res; 1988 Apr 15; 20(4):230-4. PubMed ID: 2840381
    [Abstract] [Full Text] [Related]

  • 19. Effects of sodium-valproate administration on plasma ACTH levels in patients with ACTH hypersecretion.
    Ambrosi B, Bochicchio D, Riva E, Faglia G.
    J Endocrinol Invest; 1983 Aug 15; 6(4):305-6. PubMed ID: 6315806
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.